RTM Diagnostika

Russia
Sosnovka, Kirov Oblast, Russia, 105082

Company profile

RTM Diagnostika company profile

Diagnostic microwave radio RTM-01-RES The temperature and rate of growth of malignant tumors Cancer is the terrible disease of breast. That is why the full range of diagnostic measures in mammalogy aimed primarily at identifying it. It is known that the malignant tumor has a higher temperature compared with surrounding tissues. These data were first obtained Guture M. French scientist, who, after more than 550 invasive measurements demonstrated that malignancy is determined by its temperature is doubling time. Therefore, the most dangerous, rapidly growing tumors have a very high temperature. It is also known that thermal changes, usually preceded by structural changes. In particular, the thermal changes of the mammary glands come not a moment when the cancer reaches the required size, but much earlier. Studies have shown that even at the stage preceding the malignant growth, namely, when the cells have the expressed proliferation, accompanied by atypical changes, increases the density of microcapillary network, and as a consequence there is a local increase in temperature. Indisputable is the fact that patients with these changes have a high risk of malignancy. Many authors classify this condition as precancerous. The internal temperature - measure of angiogenesis In 2003, Japanese scientists have shown that the temperature in the cancerous region determined by the density microcapillary network (microvessel density (MVD) [8]. This is the main parameter that characterizes angiogenesis. The density of the microcapillary network when proliferation atypia several times greater than the rate for normal tissues and characterizes the risk of malignancy. in addition, the microcapillary network density refers to the probability of transformation from noninvasive to invasive cancer, the probability of metastasis and tumor growth rate. Therefore, the internal temperature, as a measure of angiogenesis, provides important information about the development of cancer.

Business identity

Contact email
[email protected]
Phone number
+74952294183
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2005-12-01

Headquarters

Postal code
105082
Country code
RU
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$247,417
Last funding
Seed / $247,417 / 2016-06-22
Last equity funding
Seed / $247,417
Investors
3
Founders
1

Founders and investors

Founders

Sergey Vesnin

Investors

BiofundModernization and Technology Development FundMoscow Seed Fund